Soleno Therapeutics (SLNO)

• Market cap: $2.07B
• 1 day: -3.55%
• 5 days: -4.19%
• 1 month: -7.01%
• 3 months: -19.07%
• 6 months: -53.66%
• Year to date: -18.1%
• 1 year: -23.12%
• 5 years: -10.27%
• 10 years: -58.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152